发明名称 HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS
摘要 The present invention encompasses compounds of the formula (I);wherein the groups ring A and Cy are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
申请公布号 US2014275012(A1) 申请公布日期 2014.09.18
申请号 US201414209280 申请日期 2014.03.13
申请人 BOSANAC Todd;BURKE Michael J.;DISALVO Darren;MAO Wang;WESTBROOK John 发明人 BOSANAC Todd;BURKE Michael J.;DISALVO Darren;MAO Wang;WESTBROOK John
分类号 C07D277/56;C07D417/04;C07D487/08;C07D487/10 主分类号 C07D277/56
代理机构 代理人
主权项 1. A compound of the formula (I) Cy is aryl, heteroaryl or heterocycle, each is substituted by R1 and optionally substituted by halogen, halo C1-4 alkyl, C1-4 alkyl and C1-4 alkoxy; R1 is chosen from: L-Ar, C1-6 alkyl, —S(O)m—R3 and C1-6 alkoxy, each Ar, C1-6 alkyl and C1-6 alkoxy are optionally substituted by halogen, halo C1-4 alkyl, C1-4 alkyl, R2—S(O)m—, —CN, —C(O)—N(R3)2 or C1-4 alkoxy; L is a linker chosen from a bond, O, >C(O), —(CH2)n—, —O—(CH2)n—, —N(R3)—, —N(R3)—(CH2)n—, —(CH2)n—N(R3)—, —C(O)—N(R3)—, —C(O)—N(R3)—(CH2)n—, —N(R3)—C(O)—N(R3)—, —N(R3)—C(O)—, —S(O)m—N(R3)—, R3—S(O)m—, and —N(R3)—S(O)m—, wherein the —CH2— in each L can have 1-2 hydrogens replaced by C1-3 alkyl, said C1-3 alkyl groups can optionally cyclize to form a C3-6 cycloalkyl ring; Ar is carbocycle, heterocycyl or heteroaryl; Ring A of the formula (I) is an N-linked heterocycle chosen from C5-C10 spirocycle and a nitrogen containing optionally bridged mono- or bi-cyclic heterocycle, each Ring A is substituted by one Y and optionally substituted by halogen, halo C1-4 alkyl, C1-4 alkyl and C1-4 alkoxy; Y is —(CH2)n—N(R3)—R4, or Y is R4, R4 is  wherein R5 cannot be hydrogen, each n is independently 1-4; each m is independently 0-2; each R2 and R3 are independently chosen from hydrogen or C1-4 alkyl; each R5 is independently chosen from hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 alkylC1-4alkoxy, C1-4 alkylhydroxy, —(CH2)n-heterocycle and heterocycle each heterocycle optionally substituted by halogen, OH or R2—S(O)m—; each group defined above for Cy, R1-R5, and Y can be where possible partially or fully halogenated; or a pharmaceutically acceptable salt thereof.
地址 New Milford CT US